Cat.No. |
Product Name |
Information |
Area |
T7089 |
SGC2085 |
SGC2085 is an effective and selective coactivator-associated arginine methyltransfera... |
|
T4583 |
(R)-PFI-2 hydrochloride |
PFI-2 hydrochloride is a potent, highly selective, and cell-active inhibitor of the m... |
|
T4393 |
MS049 2HCl (1502816-23-0(free base)) |
MS049 is a potent and selective inhibitor of PRMT4 (IC50 = 34 nM) and PRMT6 (IC50 = 4... |
|
T4378 |
MS049 |
MS 049 is a potent, selective, and cell-active dual inhibitor of PRMT4 and PRMT6 with... |
|
T4343 |
A-196 |
A-196 is a potent and selective inhibitor of SUV420 h1 and SUV420 h2 with IC50 values... |
|
T4334 |
EPZ020411 2HCl (1700663-41-7(free base)) |
EPZ020411 is an effective and specific small molecule PRMT6 inhibitor (IC50=10 nM). |
Cancer |
T4314 |
EPZ020411 |
EPZ020411 is a specific and effective inhibitor of PRMT6 (IC50=10 nM). |
cancer |
T3624 |
A-366 |
Potent and selective G9a/GLP histone lysine methyltransferase inhibitor (IC50?= 3.3 n... |
|
T3084 |
SGC707 |
SGC707 is a potent, selective, and cell-active allosteric inhibitor of PRMT3. |
Others |
T6916 |
OICR-9429 |
OICR-9429 is a potent antagonist of the interaction that WDR5 effect with peptide reg... |
Others |
T6900 |
MS023 |
MS023 is a potent, selective, and cell-active Type I PRMT inhibitor with IC50 of 30 n... |
Others |
T6879 |
LLY-507 |
LLY-507 is an effective, cell-active, and specific inhibitor of protein-lysine Methyl... |
Others |
T6857 |
HLCL-61 hydrochloride |
HLCL-61 hydrochloride is a potent and selective PRMT5 inhibitor for the treatment of ... |
Others |
T6853 |
GSK591 |
GSK591,Alternative Names are EPZ015866, GSK3203591, is a potent selective inhibitor o... |
Others |
T6810 |
CPI-360 |
CPI-360 is a potent, selective,and SAM-competitive EZH1 inhibitor with IC50 of 102.3 ... |
Others |
T6809 |
CPI-169 |
CPI-169 is a potent, and selective EZH2 inhibitor with IC50 of 0.24 nM, 0.51 nM, and ... |
Others |
T6803 |
Chaetocin |
Chaetocin, a natural product from Chaetomium species, is a histone methyltransferase ... |
Others |
T3257 |
UNC0638 |
UNC0638 is an inhibitor of β-protein lysine methyltransferases G9a(IC50<15 nM) and GL... |
|
T3201 |
WDR5-0103 |
WDR5-0103 is an effective and specific WD repeat-containing protein 5 (WDR5) antagoni... |
Cancer |
T6484 |
EI1 |
EI1 is a potent and selective EZH2 inhibitor with IC50 of 15 nM and 13 nM for EZH2 (W... |
|
T2649 |
MI-2 |
MI-2 (Menin-MLL Inhibitor) is a potent menin-MLL interaction inhibitor with IC50 of 4... |
Cancer |
T2643 |
MI-3 |
MI-3 (Menin-MLL Inhibitor) is an effective inhibitor of Menin-MLL interaction (IC50: ... |
Cancer |
T6076 |
EPZ015666 |
EPZ015666 is an orally available inhibitor of PRMT5 enzymatic activity. |
Cancer |
T6059 |
GSK343 |
GSK343,a specific and effective EZH2 inhibitor (IC50=4 nM), exhibits 60 fold specific... |
Cancer |
T3099 |
Pinometostat |
EPZ5676 has been used in trials studying the treatment of Leukemia, Acute Leukemias, ... |
Cancer |
T3082 |
SGC0946 |
SGC0946 is a highly effective and specific DOT1L methyltransferase inhibitor (IC50: 0... |
Cancer |
T3081 |
EPZ004777 |
EPZ004777 is a potent, selective?DOT1L?inhibitor with?IC50?of 0.4 nM. |
|
T3057 |
UNC1999 |
UNC1999 is a orally bioavailable, effective and specific inhibitor of EZH2 (IC50=2 nM... |
Cancer |
T2435 |
EPZ011989 |
EPZ011989 is a effective, specific orally bioavailable EZH2 inhibitor with Ki < 3 nM ... |
Cancer |
T2354 |
UNC0631 |
UNC0631 is a effectvie histone methyltransferase G9a inhibitor (IC50=4 nM). |
Other |